期刊文献+

脂肪细胞型脂肪酸结合蛋白与老年人2型糖尿病下肢血管病变的关系 被引量:6

The relationship between adipocyte fatty acid binding protein and lower limb vascular disease in the elderly with type 2 diabetes
原文传递
导出
摘要 目的 探讨血浆脂肪细胞型脂肪酸结合蛋白(A FABP)与老年2型糖尿病(T2DM)患者下肢血管病变程度的关系. 方法 选择老年T2DM患者1 26例进行双下肢高分辨彩色多普勒检查,根据其下肢血管病变程度分为单纯T2DM组42例,合并轻度下肢动脉粥样硬化组(轻度硬化组)40例,合并重度下肢动脉粥样硬化组(重度硬化组)44例;并选择同期健康体检者40例为对照组.采用ELISA方法测定空腹血浆A-FABP水平,检测血糖、血脂、胰岛素抵抗指数(HOMR-IR)、超敏C反应蛋白(hs CRP)、肾小球滤过率等代谢指标. 结果 血浆A-FABP水平比较,对照组(4.5±1.7)μg/L<单纯T2DM组(6.1±2.1)μg/L<轻度硬化组(7.2±2.3)μg/L<重度硬化组(8.4±3.2)μg/L,差异有统计学意义(P<0.01).而且随着踝肱指数的降低和下肢血管内膜中层厚度的升高,血浆A FABP也随之升高.多因素Logistic回归分析结果显示,血浆A-FABP水平是老年T2DM患者发生下肢血管病变的主要影响因素之一(P<0.01).多元逐步回归分析显示,低密度脂蛋白、糖化血红蛋白、H()MR-IR、hs CRP是老年T2DM患者血浆A-FABP的独立预测因子. 结论 血浆A-FABP与老年T2DM患者下肢血管病变程度相关,在老年T2DM患者下肢血管病变的发生中起重要作用. Objective To explore the relationship between adipocyte fatty acid binding protein (A-FABP) and lower limb vascular disease (LLVD) in the elderly with type 2 diabetes(T2DM).Methods Bilateral lower limb vessels were checked by the High Resolution Color Doppler in all the subjects,including 40 healthy subjects as control (group A),126 T2DM patients.42 T2DM patients had no LLVD (group B),40 had mild LLVD (group C),and 44 had severe LLVD (group D).The levels of plasma A-FABP,blood glucose,lipid profiles,HOMA-IR,hypersensitive C reactive protein (hs CRP),and e-glomerular filtration rate were determined.Results The levels of plasma A-FABP were in the following ascending order of group A(4.5± 1.7)μg/L〈group B(6.1±2.1)μg/L〈group C (7.2 ± 2.3)μg/L 〈 group D (8.4 ± 3.2)μg/L (P〈 0.01).A-FABP levels elevated along with the decrease of ABI and the increase of L IMT.Multiple logistic regression analysis showed that A FABP levels was main influencing factor of lower limb vascular disease (LLVD) in the elderly with type 2 diabetes.LDL C,HbA1c,HOMR-IR,hs-CRP were the predictive factors for the plasma A-FABP levels in the elderly with T2DM after multiple stepwise regression analysis.Conclusions For elder T2DM patients,the level of plasma A FABP is correlated with the degree of LLVD,and plays an important role in the progress of LLVD.
出处 《中华老年医学杂志》 CAS CSCD 北大核心 2014年第10期1085-1088,共4页 Chinese Journal of Geriatrics
关键词 脂肪酸结合蛋白质类 糖尿病 2型 糖尿病血管病变 外周血管疾病 Fatty acid-binding proteins Diabetes mellitus, type 2 Diabetic angiopathies Peripheral vascular diseases
  • 相关文献

参考文献9

  • 1KralischS,Fasshauer M.Adipocyte fatty acid binding protein:a novel adipokine involved in the pathogenesis of metabolic and vascular disease[J]?Diabetologia,2013,56:10-21.
  • 2Furuhashi M,Tuncman G,Grgün CZ,et al.Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2[J].Nature,2007,447:959-965.
  • 3谭擎缨,王静,阮芸,余秀华.2型糖尿病下肢血管病变的超声检查及相关因素研究[J].中华糖尿病杂志(1006-6187),2005,13(6):416-417. 被引量:25
  • 4Lee K,Santibanez-Koref M,Polvikoski T,et al.Increased expression of fatty acid binding protein 4 and leptin in resident macrophages characterises atherosclerotic plaque rupture[J].Atherosclerosis,2013,226:74-81.
  • 5Stefanska A,Ponikowska I,Sypniewska G.A-FABP concentration is more strongly associated with cardiometabolic risk factors and the occurrence of metabolic syndrome in premenopausal than in postmenopausal middle-aged women[J].Biomed Res Int,2014,2014:645762.
  • 6Yoo H J,Kim S,Park MS,et al.Serum adipocyte fatty acid-binding protein is associated independently with vascular inflam-mation:analysis with (18) F-fluorodeoxyglucose positron emission tomography[J].J Clin Endocrinol Metab,2011,96:E488 E492.
  • 7Peeters W,de Kleijn DP,Vink A,et al.Adipocyte fatty acid binding protein in atherosclerotic plaques is associated with local vulnerability and is predictive for the occurrence of adverse cardiovascular events[J].Eur Heart J,2011,32:1758-1768.
  • 8Tuncman G,Erbay E,Hom X,et al.A genetic variant at the fatty acid-binding protein aP2 locus reduces the risk for hypertriglyceridemia,type 2 diabetes,and cardiovascular disease[J].Proc Natl Acad Sci USA,2006,103:6970-6975.
  • 9谭中菊,杨云梅.血糖控制对2型糖尿病患者血管病变影响的研究进展[J].中华老年医学杂志,2014,33(1):104-107. 被引量:12

二级参考文献28

  • 1余秀华,李黎,施红,徐爱芬,张宏.彩色多普勒超声对糖尿病下肢动脉病变的观察[J].东南国防医药,2003,5(4):279-280. 被引量:6
  • 2Adler AI,Stratton IM,Neil HA. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36):prospective observational study[J].British MedJ,2000.412-419.
  • 3Kar P,Holt RI. The effect of sulphonylureas on the microvascular and macrovascular complications of diabetes[J].{H}Cardiovascular Drugs and Therapy,2008.207-213.
  • 4UK Prospective Diabetes Study (UKPDS) Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS33)[J].{H}LANCET,1998.837-853.
  • 5Holman RR,Paul SK,Bethel MA. 10-year follow-up of intensive glucose control in type 2 diabetes[J].{H}New England Journal of Medicine,2008.1577-1589.
  • 6The diabetes control and complications trial/epidemiology of diabetes interventions and complications (DCCT/EDIC) study research group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes[J].{H}New England Journal of Medicine,2005.2643-2653.
  • 7Meinert CL,Knatterud GL,Prout TE. A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes.Ⅱ.Mortality results[J].Diabetes,1970.789-830.
  • 8Genuth S. Exogenous insulin administration and cardiovascular risk in non-insulin-dependent and insulin-dependent diabetes mellitus[J].{H}ANNALS OF INTERNAL MEDICINE,1996.104-109.
  • 9Duckworth W,Abraira C,Moritz T. Glucose control and vascular complications in veterans with type 2 diabetes[J].{H}New England Journal of Medicine,2009.129-139.
  • 10Gerstein HC,Miller ME,Byington RP. Effects of intensive glucose lowering in type 2 diabetes[J].{H}New England Journal of Medicine,2008.2545-2559.

共引文献35

同被引文献33

引证文献6

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部